Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis

Junzhe Chen, Xiaoqi Feng, Yan Zhou, Y. Wang, Shune Xiao, Chengliang DengFrontiers in Oncology 2025 · DOI

Abstract

Chronic lymphedema is a progressive and debilitating condition characterized by lymphatic fluid accumulation and subsequent tissue fibrosis. This systematic review and meta-analysis evaluates the efficacy of liposuction-based treatments, specifically comparing standalone liposuction (LS) with integrated liposuction (LSI), which combines fat removal with physiological microsurgery. Our findings suggest that while LS provides superior volume reduction, LSI offers significant advantages in functional recovery and reduced dependence on lifelong compression garments.

Introduction

Lymphedema affects approximately 250 million people worldwide, presenting a significant global health burden. The condition often progresses from fluid accumulation to permanent tissue changes, including fibrosis and adipose deposition, known as non-pitting lymphedema. Traditional management has focused on "debulking" through liposuction (LS), which effectively removes excess tissue but fails to address the underlying lymphatic insufficiency. Consequently, patients undergoing LS typically require lifelong, continuous compression therapy to maintain results.

Recent surgical advancements have introduced "Integrated Liposuction" (LSI), which pairs liposuction with physiological procedures such as Lymphovenous Anastomosis (LVA) or Vascularized Lymph Node Transfer (VLNT). This study aims to determine if LSI can match the volume reduction of LS while simultaneously restoring lymphatic function and alleviating the burden of permanent compression.

Methodology

The researchers conducted a comprehensive systematic review and meta-analysis in accordance with PRISMA and AMSTAR guidelines. The search spanned major medical databases, including PubMed, Embase, and Web of Science, covering literature published between 1996 and 2024.

PRISMA 2020 flow diagram illustrating the study selection process.

From an initial pool of 1,220 records, 52 studies involving 2,334 patients were selected for qualitative review. Of these, 23 studies (n=1,028 patients) met the criteria for quantitative meta-analysis. Due to the high heterogeneity observed across studies ($I^2 > 90\%$), a random-effects model was employed using Stata MP 18.0. Primary outcomes measured included limb volume reduction, postoperative compression dependence, cellulitis incidence, and Quality of Life (QOL) scores.

Key Findings

Volume Reduction vs. Functional Restoration

The meta-analysis revealed a distinct trade-off between volume reduction and functional restoration. Standalone LS achieved a remarkable 99.74% reduction in excess limb volume. In contrast, integrated LSI achieved a slightly lower reduction of 87.31%. This difference is attributed to the surgical necessity in LSI to preserve some subcutaneous tissue to protect newly reconstructed lymphatic pathways.

Breaking the Compression Cycle

One of the most significant advantages of LSI is the potential for "down-titration" of compression therapy. While LS patients must adhere to a strict 24/7 compression regimen indefinitely, many LSI patients were able to transition to "night-only" compression or discontinue garment use entirely. This shift represents a major improvement in patient autonomy and daily comfort.

Infection Control and Quality of Life

Both LS and LSI demonstrated a significant protective effect against skin infections. The pooled data showed a reduction of 1.30 infectious episodes per year following surgery. By removing the stagnant, protein-rich fluid that serves as a medium for bacteria, these procedures effectively improve the local immune environment. Furthermore, patients reported significant improvements in QOL, particularly regarding physical appearance and emotional well-being, as measured by validated scales like LYMQOL and SF-36.

Discussion

The analysis confirms that liposuction-based treatments are highly effective for both upper and lower limb lymphedema. The previous concern that gravity might hinder lower-limb outcomes was not supported by the data, which showed comparable volume reduction across both anatomical sites (91.08% for lower limbs vs. 92.83% for upper limbs).

However, several limitations persist in the current literature. The high heterogeneity in surgical techniques and postoperative protocols makes establishing a universal "gold standard" challenging. Additionally, the relatively short follow-up periods in many studies may underestimate the long-term benefits of physiological repairs like VLNT, which can take years to reach full efficacy.

Conclusion

Liposuction-based treatments are transformative for patients with chronic lymphedema. While standalone liposuction remains the gold standard for pure volume reduction, integrated approaches (LSI) offer a superior path toward functional independence by reducing reliance on compression garments. Future research should focus on large-scale Randomized Controlled Trials (RCTs) and standardized reporting of "compression-free days" to further refine clinical guidelines and optimize patient outcomes.

Identifier: CRD42024616130 (PROSPERO)

Summary updated

Abstract

https://www.crd.york.ac.uk/PROSPERO, identifier CRD42024616130.
BibTeX
@inproceedings{chen2025outcomes,
  author = {Junzhe Chen and Xiaoqi Feng and Yan Zhou and Y. Wang and Shune Xiao and Chengliang Deng},
  title = {{Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis}},
  booktitle = {Frontiers in Oncology},
  year = {2025},
  doi = {10.3389/fonc.2025.1651472},
}
Figure